Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Octet® HTX System

Product Image
Product Description

The Octet HTX instrument monitors up to 96 biosensors simultaneously, enabling label-free detection for protein quantitation and kinetic characterization at unmatched speed. The system's ability to read 8, 16, 32, 48 or 96 wells in parallel lets you tailor your assay design to maximize analytical throughput or sensitivity. Rapid whole-plate detection is accomplished using the 96 biosensor mode, providing either quantitation data for 96 samples in as little as 2 minutes or full plate kinetic screening in minutes instead of hours. The 8 and 16 biosensor modes provide high sensitivity for measuring small molecule binding interactions and protein quantitation down to 50 ng/mL. The 32 or 48 biosensor modes enable larger complex assays such as epitope binning or multi-step quantitation to be analyzed in the shortest amount of time. Key applications that leverage the unique strengths of the Octet HTX system include epitope binning experiments, off-rate ranking, and titer concentration.

Key Features

The Octet HTX system offers unmatched performance, flexibility and throughput.
•    Up to 96-well simultaneous sampling
•    384-well and 96-well formats
•    Quantitate 96 samples in as little as two minutes
•    Two plate locations maximize throughput and improve workflow
•    Automation friendliness allows multiple-plate assays in one run
•    Biosensor re-racking allows maximum flexibility and operational cost savings
•    Advanced software tools for epitope binning analysis

Product Octet® HTX System
Company ForteBio
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

ForteBio
Menlo Science & Technology Park 1360 Willow Road, Suite 201 Menlo Park, CA 94025 USA

Tel: 650.322.1360
Fax: Fax: 650.322.1370
Email: fortebio_info@pall.com



Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!